SIRT7 and bladder transitional cell carcinoma: The observed decreased overall survival in BlCa patients with lower SIRT7 expression in TCGA cohort (eventually associated with higher grade and stage, as well as molecular BlCa subtype) further suggests that decreased SIRT7 impacts on neoplastic cell biology, promoting a more aggressive phenotype.